NCT06851520

Brief Summary

This retrospective observational study evaluates the effects of different Quadratus Lumborum Block (QLB) techniques on postoperative recovery and total opioid consumption in patients undergoing radical cystectomy under general anesthesia. The study will analyze intraoperative and postoperative patient records from October 15, 2023, to October 15, 2024, at Tekirdağ Namık Kemal University Hospital. Patients who received anterior or posterior QLB for postoperative analgesia will be included. Data collection will involve demographic information, total opioid consumption (morphine milligram equivalents), recovery quality scores (QoR-15), postoperative pain scores (Visual Analog Scale, VAS), time to first rescue analgesic administration, frequency of rescue analgesic use, and incidence of postoperative nausea and vomiting (PONV). The retrospective analysis will compare the two QLB techniques to determine if there is a significant difference in postoperative opioid consumption and recovery quality. Statistical methods will be used to assess pain scores over time, opioid consumption, and overall recovery quality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 24, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 28, 2025

Completed
Last Updated

February 28, 2025

Status Verified

February 1, 2025

Enrollment Period

1 year

First QC Date

February 24, 2025

Last Update Submit

February 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total Opioid Consumption (Morphine Milligram Equivalents) in the First 24 Hours

    The total amount of opioids (converted to morphine milligram equivalents) administered postoperatively within the first 24 hours following radical cystectomy. Continuous variable (mg of morphine equivalent)

    0-24 hours postoperatively

Secondary Outcomes (5)

  • Pain Scores Using Visual Analog Scale (VAS) at Multiple Time Points

    0, 2, 6, 12, and 24 hours postoperatively

  • Postoperative Recovery Quality (QoR-15 Score)

    24 hours postoperatively

  • Time to First Rescue Analgesic Administration

    0-24 hours postoperatively

  • Frequency of Rescue Analgesic Use

    0-24 hours postoperatively

  • Incidence of Postoperative Nausea and Vomiting (PONV)

    0-24 hours postoperatively

Study Arms (2)

Anterior QLB Group

Patients who underwent radical cystectomy under general anesthesia and received anterior quadratus lumborum block (QLB) for postoperative analgesia.

Procedure: Anterior Quadratus Lumborum Block (QLB)

Posterior QLB Group

Patients who underwent radical cystectomy under general anesthesia and received posterior quadratus lumborum block (QLB) for postoperative analgesia.

Procedure: Posterior Quadratus Lumborum Block (QLB)

Interventions

A regional anesthesia technique where local anesthetic is injected anterior to the quadratus lumborum muscle under ultrasound guidance for postoperative pain management.

Anterior QLB Group

A regional anesthesia technique where local anesthetic is injected posterior to the quadratus lumborum muscle under ultrasound guidance for postoperative pain management.

Posterior QLB Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study includes adult patients (18-65 years old) who underwent radical cystectomy under general anesthesia at Tekirdağ Namık Kemal University Hospital between October 15, 2023, and October 15, 2024. Patients were retrospectively selected based on the administration of anterior or posterior Quadratus Lumborum Block (QLB) for postoperative analgesia. Patients with complete medical records were included, while those with missing data, coagulopathy, chronic opioid use, or unplanned open surgery conversion were excluded.

You may qualify if:

  • Patients who underwent radical cystectomy under general anesthesia between October 15, 2023, and October 15, 2024.
  • Patients who received anterior or posterior quadratus lumborum block (QLB) for postoperative analgesia.
  • Age: 18-65 years.
  • ASA Physical Status Classification: I-III.
  • BMI \< 35 kg/m².
  • Complete medical records available for retrospective review.

You may not qualify if:

  • Patients who received a different postoperative analgesia technique (e.g., epidural, TAP block).
  • Incomplete or missing medical records.
  • Psychiatric disorders that could affect pain perception and reporting.
  • Coagulopathy or bleeding disorders.
  • Hepatic or renal failure.
  • Chronic opioid use before surgery.
  • Patients who required unplanned conversion to open surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tekirdağ Namık Kemal University Hospital

Tekirdağ, Turkey (Türkiye)

Location

Related Publications (1)

  • Korgvee A, Veskimae E, Huhtala H, Koskinen H, Tammela T, Junttila E, Kalliomaki ML. Posterior quadratus lumborum block versus epidural analgesia for postoperative pain management after open radical cystectomy: A randomized clinical trial. Acta Anaesthesiol Scand. 2023 Mar;67(3):347-355. doi: 10.1111/aas.14188. Epub 2023 Jan 3.

    PMID: 36547262BACKGROUND

MeSH Terms

Conditions

Urinary Bladder Neoplasms

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 24, 2025

First Posted

February 28, 2025

Study Start

October 15, 2023

Primary Completion

October 15, 2024

Study Completion

December 15, 2024

Last Updated

February 28, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations